In this study, we investigated the impact of TLR2 and TLR4 SNPs on susceptibility of AML patients towards developing sepsis, pneumonia and fever during severe neutropenia following intensive chemotherapy as well as its impact on the patient’s outcome. The gene discussed is TLR2; the disease is susceptibility to pneumonia measurement.